A randomized, double-blind, placebo-controlled trial of Abaloparatide men with osteoporosis at high risk for fracture
Phase of Trial: Phase III
Latest Information Update: 30 Mar 2018
At a glance
- Drugs Abaloparatide (Primary)
- Indications Osteoporosis
- Focus Registrational; Therapeutic Use
- Acronyms ATOM
- Sponsors Radius Health Inc.
- 30 Mar 2018 Status changed from planning to recruiting, according to a Radius Health media release.
- 21 Nov 2017 New trial record
- 02 Nov 2017 According to Radius media release,the compnay expect to initiate this trial in the first quarter of 2018.